About Senmiao Technology Limited - Common Stock (AIHS)
Senmiao Technology Ltd is a technology-focused company that primarily operates in the transportation and ride-hailing sectors, primarily in China. It provides innovative solutions through its software and platform services that facilitate efficient vehicle leasing and ride-hailing operations. The company leverages cutting-edge technology to enhance user experiences and streamline operations for both drivers and passengers. In addition to its core business, Senmiao is exploring opportunities in the electric vehicle space, aiming to adapt to the growing demand for sustainable transportation solutions. With a commitment to enhancing mobility, Senmiao Technology plays a significant role in the evolving landscape of urban transportation. Read More
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Power Metallic Mines Inc. (TSX.V: PNPN) (OTCQB: PNPNF) has announced high-grade results from its Winter 2025 drill program, including a standout intercept of 12.54 meters at 10.99% CuEq from hole PML-25-012a at the Lion Zone . The interval includes 3.10 g/t gold, 25.52 g/t silver, 4.09% copper, 12.06 g/t palladium, and 2.00 g/t platinum.
Gainers Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares surged 106.8% to $5.77 in pre-market trading. The stock began trading on a 1:18 reverse split on July 10.
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a second-quarter revenue increase of 96% year-over-year to $12.58 million, beating the consensus of $9.75 million.
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
